NCT06413680
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06413680
Title A First-In Human (FIH) Trial to Find Out if REGN10597 is Safe and How Well it Works for Adult Participants With Advanced Solid Organ Malignancies
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Regeneron Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Usc Norris Comprehensive Cancer Center RECRUITING Los Angeles California 90033 United States Details
University of California San Francisco (UCSF) RECRUITING San Francisco California 94143 United States Details
Yale School of Medicine RECRUITING North Haven Connecticut 06473 United States Details
University of Chicago RECRUITING Chicago Illinois 60637 United States Details
Start Midwest Cancer Research RECRUITING Grand Rapids Michigan 49546 United States Details
Northwell Health RECRUITING Lake Success New York 11042 United States Details
University of North Carolina at Chapel Hill RECRUITING Chapel Hill North Carolina 27514 United States Details
University of Pittsburgh Medical Center - Hillman Cancer Center RECRUITING Pittsburgh Pennsylvania 15232 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
Next Oncology RECRUITING San Antonio Texas 78229 United States Details
The Start Center for Cancer Care RECRUITING San Antonio Texas 78229 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field